↓ Skip to main content

Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men

Overview of attention for article published in Calcified Tissue International, February 2018
Altmetric Badge

Mentioned by

facebook
2 Facebook pages

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
46 Mendeley
Title
Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men
Published in
Calcified Tissue International, February 2018
DOI 10.1007/s00223-018-0398-0
Pubmed ID
Authors

Lana J. Williams, Michael Berk, Jason M. Hodge, Mark A. Kotowicz, Amanda L. Stuart, Vinoomika Chandrasekaran, Jasmine Cleminson, Julie A. Pasco

Abstract

Selective serotonin reuptake inhibitors (SSRIs) have been shown to have a clinically significant impact on bone metabolism. To explore this further, we aimed to determine whether these agents are associated with serum markers of bone turnover utilising a population-based sample of men (n = 1138; 20-96 year) participating in the Geelong Osteoporosis Study. Blood samples were obtained and the bone resorption marker, C-telopeptide (CTx) and formation marker, type 1 procollagen amino-terminal-propeptide (PINP) were measured. Anthropometry and socio-economic status (SES) were determined and information on medication use and lifestyle was obtained via questionnaire. Lifetime mood disorders were assessed using semi-structured clinical interviews. Thirty-seven (3.3%) men reported using SSRIs. Age was an effect modifier in the association between SSRIs and markers of bone turnover. Among younger men (20-60 year; n = 557), adjusted mean CTx and PINP values were 12.4% [16.7 (95% CI 14.6-18.8) vs 19.1 (95% CI 18.7-19.4) pg/ml, p = 0.03] and 13.6% [5.6 (95% CI 4.9-6.3) vs 6.4 (95% CI 6.3-6.6) pg/ml, p = 0.02] lower among SSRI users compared to non-users, respectively. No differences in SSRI use and markers of bone turnover were detected among older men (61-94 year; all p > 0.05). These patterns persisted after further adjustment for activity, alcohol, smoking, SES, depression, bone active medications and other antidepressants. Our data suggest that SSRI use is associated with alterations in bone turnover markers among younger men. The observed decreases in both CTx and PINP are likely to contribute to a low bone turnover state and increased skeletal fragility with this potential imbalance between formation and resorption resulting in subsequent bone loss.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 15%
Student > Master 6 13%
Researcher 6 13%
Student > Bachelor 5 11%
Student > Postgraduate 2 4%
Other 4 9%
Unknown 16 35%
Readers by discipline Count As %
Medicine and Dentistry 12 26%
Nursing and Health Professions 3 7%
Social Sciences 3 7%
Agricultural and Biological Sciences 2 4%
Sports and Recreations 2 4%
Other 5 11%
Unknown 19 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2020.
All research outputs
#18,587,406
of 23,023,224 outputs
Outputs from Calcified Tissue International
#1,494
of 1,780 outputs
Outputs of similar age
#334,984
of 446,078 outputs
Outputs of similar age from Calcified Tissue International
#28
of 30 outputs
Altmetric has tracked 23,023,224 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,780 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,078 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.